- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Pozen Inc (PZ6)
| Open: | 3.794 | Day's Range: | 3.764 - 3.794 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 3.864 | 52wk Range: | 3.393 - 5.785 | 1-Yr Rtn: | -29.74% |
Key Statistics for PZ6
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -0.1700 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 72 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PZ6
Company Profile & Key Executives for PZ6
POZEN Inc. is a pharmaceutical company that develops therapeutics for diseases with unmet medical needs. The Company's product candidates include migraine treatments as well as is exploring the development of product candidates in other pain-related therapeutic areas.
| John R PlachetkaChairman/President/CEO | John G FortChief Medical Officer |
| Elizabeth A Cermak "Liz"Exec VP/Chief Commercial Ofcr | Tomas S BocanegraExec VP:Product Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PZ6 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page